COVID19
COVID19
COVID19
2020)
Authors:
Jaime van der Eb, Head of Claims & Defence, Hydor AS, and
Dr. Alina Kuznetsova, Medical Product Director, Global Voyager Assistance
Introduction
In December 2019 there was a cluster of pneumonia cases in China. Investigations found
that it was caused by a previously unknown strain of the Coronavirus family. This strain of
the virus has now been named COVID-19.
The World Health Organization has declared the outbreak of COVID-19 to be a Public Health
Emergency of International Concern, a categorization reserved for the most serious
epidemics.
As concern over COVID 19 has increased, so has the risk posed by misinformation regarding
the virus. The South China Morning Post, for example, has reported that a woman who,
having read online that raw garlic could help protect her from the virus, was hospitalised
with a severely inflamed throat after reportedly consuming 1.5kg of raw garlic. There is no
direct medical evidence that garlic will significantly reduce the risk of a COVID-19 infection.
Incidents like this highlight the importance of owners ensuring that they, and their crews,
follow legitimate medical advice regarding COVID-19.
With this in mind, we have partnered with the medical doctors of our specialist medical
repatriation partner Global Voyager Assistance (https://gvassistance.com/en/) to write the
following article. This article sets out, as of the date of writing, a non-exhaustive list of
measures which ship owners and their crews may wish to adopt to reduce the risk posed by
COVID-19.
What is COVID-19?
COVID-19 is the name of a new strain of Coronavirus. Coronaviruses are a large group of
viruses. They consist of a core of genetic material surrounded by an envelope of protein
spikes; this gives the virus the appearance of a crown, when viewed through a microscope.
The Latin name for a crown is “corona”. This is the origin of the name of this group of
viruses.
There are different types of Coronavirus, some cause respiratory symptoms others
gastrointestinal symptoms.
In most people the symptoms of the respiratory Coronavirus diseases tend to be mild, like
those of the common cold. There are, however, some types of Coronavirus which cause
severe/acute symptoms (e.g. Severe Acute Respiratory Syndrome (“SARS”), first identified in
China in 2003, and the Middle East Respiratory Syndrome (“MERS”) first identified in Saudi
Arabia in 2012.
COVID-19 can cause respiratory symptoms and, in some cases, these can be severe
(meaning that it can be difficult for some sufferers to breathe).
What are the symptoms of COVID-19?
From what healthcare professionals currently know:
1. Symptoms can occur between 2 and 14 days from exposure to the virus, however,
some medical sources state that incubation periods can be up to 21 days.
2. Symptoms range from:
a. Minor ailments like fever, sore throat, fatigue, dry coughing and a runny
nose, to
b. Serious symptoms such as difficulty in breathing, high fever and painful
coughing.
Many people with the virus look and feel like they have ‘flu’.
Elderly people (from 60 years old and above), and those with pre-existing health conditions
(e.g. chronic lung problems, oncological or severe autoimmune diseases) are more likely to
experience severe symptoms and these may lead to fatal outcomes.
The World Health Organization (“WHO”) currently estimates the COVID-19 fatality rate to be
around 3.4%. This figure may decrease as more data becomes available over time.
Can COVID-19 be transmitted from person to person?
Yes. COVID-19 is spread most often by what are known as "respiratory droplets" from an
infected person (i.e. the little secretions people generate when they sneeze or cough). For
this reason COVID-19 is often transmitted between people who have been in close contact.
GVA’s doctors inform us that COVID-19 can survive away from a host (e.g. a person) for
several hours, on smooth surfaces. In relatively warm and humid conditions COVID-19 can,
reportedly, survive for several days (e.g. with a humidity of 40% and the temperature of 20
C, the virus can remain infectious for up to five days).
For this reason, it is relatively likely that individuals will contract COVID-19 by touching
surfaces which have been contaminated with the virus.
How is COVID-19 diagnosed?
Nose and throat swabs are taken from individuals suspected of being infected with COVID-
19. A DNA test is run on the samples, obtained from the swabs, to see if the DNA of the
2
COVID-19 virus is present. If COVID-19 DNA is found, then the test subject is highly likely to
be infected with COVID-19.
What is the treatment for COVID-19?
There is no specific antivirus treatment against COVID-19. In most cases, a COVID-19
infection is treated in the same way as a flu infection (e.g. by treating the symptoms).
Supportive care (e.g. oxygen and intravenous hydration) may be provided for those
suffering more severe symptoms and life supporting intervention may be required for the
most serious cases.
Is a COVID-19 vaccination available?
No vaccine is currently available. The focus of healthcare authorities has been to contain the
virus through preventive measures (e.g. mass quarantine) to delay the transmission of the
virus and thus avoiding the need to treat large numbers of people simultaneously.
What precautions can owners / crew take to reduce the risk(s) posed by COVID-19?
The below guidance is not intended as an exhaustive list of measures but rather as an aid to
assured ship owners in addressing some of the risk posed to their crews and businesses.
General preventative measures
Healthy individuals are thought to have a significantly better prospect of overcoming a
COVID-19 infection.
It is, therefore, recommended that measures to generally promote health (and the proper
function of the human immune system) are taken.
It is recommended that individuals:
1. Get plenty of sleep
2. Exercise
3. Eat healthy food avoiding any new or suspicious dishes
4. Obtain appropriate vaccinations, reducing the likelihood of crew members having to
deal with COVID-19 and an additional illness simultaneously. Crew members should,
therefore, consider obtaining vaccinations against:
a. Flu, and
b. Illnesses which their vessel’s intended port of calls may expose crew
members to.
Assured ship owners may wish to consider adopting the following measures to protect their
employees:
3
A. 14 days of self-quarantine of employees who have recently visited China, Italy, Iran,
South Korea, and other areas where significant numbers of COVID-19 infections have
been reported.
B. Non-essential travel to COVID-19 at risk countries should be avoided.
C. Educate vessel crews to ensure that they can identify and monitor for COVID-19
symptoms (see details of symptoms above).
D. Isolate crewmember(s) prior to boarding if their travel or contacts significantly
increases the risk of their having been exposed to COVID-19.
E. Review contingency plans:
a. When planning voyages assess the risks associated with the intended port of
calls. If visiting a port where disembarking crew may be prohibited or require
a 14 day quarantine, plan how owners can ensure that crew members receive
the necessary treatment.
b. Does the vessel have sufficient supplies aboard for crew in the event of a 14
day quarantine?
c. Is it possible to set up respiratory isolation onboard? (i.e. ensure that air from
the cabin of a crew member who is suspected to be suffering from COVID-19
is not circulated through the vessel’s accommodation).
d. Minimise contact with shore personnel.
e. Consider sanitization plans for cargo.
4
Only persons cleared by the local port officials and the vessel’s master should be allowed on
board the vessel.
1. Those who are suspected of being sick (standard surgical face mask, designed to
reduce contamination emanating from the wearer. If a standard surgical mask is
worn, then these should be replaced every hour. Used masks should be disposed of
in a container with antiseptic solution).
2. Those dealing with individuals suspected of being sick (N95 masks which filter out
small particles from the air. NB: these masks are not recommended for use by those
who are thought to be unwell as they can make it harder to breathe).
5
Protective equipment aboard
If a vessel is expected to trade to parts of the world where large numbers of people are
reportedly infected with COVID-19 then, according to GVA, owners may wish to consider
equipping their vessels with the following:
6
While COVID-19 cannot be diagnosed through a telemedicine consultation, the advice of a
qualified medical doctor will assist the Master with deciding how to address a matter (e.g. if
the vessel should deviate and, if so, to where).
3. The vessel’s ventilation system should be turned off to avoid air exchange with the
rest of the vessel’s accommodation.
4. An area outside the isolation room should be allocated, where individual protective
gear can be removed and disinfected after visiting the patient.
7
5. Disposable cups, plates and cutlery should be used by a crew member suspected of
having contracted COVID-19. These items should be disposed of as contaminated
items/medical waste.
6. The vessel’s crew should maintain an intensive cleaning and disinfection regime
ongoing on-board.
7. If a crew member’s COVID-19 test is positive, owners should take medical advice and
consider whether crewmembers, who were in close contact with the infected
individual, should be quarantined ashore.
Key tips for cleaning and disinfecting when COVID-19 is suspected on board
If a crew member displays what are thought to be COVID-19 symptoms, all surfaces and
items thought to have been in direct contact with the COVID-19 suspect, should be
disinfected.
Crew members should:
1. Clean hard, non-porous surfaces first with detergent and water, and then by
applying a disinfectant in accordance with its product instructions. Care should be
taken to ensure the correct concentration of disinfectant is used and that sufficient
exposure time is allowed for effective disinfection.
2. Carefully remove porous materials, where possible, such as upholstery, rugs, and
carpeting that have been in contact with the suspect case. Launder in accordance
with the product instructions or dispose of the materials as described below.
Waste disposal containers in the area where a person presenting COVID-19 symptoms has
been should be emptied prior to starting surface cleaning and disinfection. Waste disposal
containers located in contaminated areas should be emptied by persons wearing PPE.
All used PPE and all soiled items (used tissues, disposable masks, tubing, linen, pillows,
blankets, mattresses not covered with an impermeable plastic covering, etc.) in the
contaminated areas, should be treated as Biohazardous waste and stored in an
impermeable plastic bag labelled “Biohazard”. The bag should be tied up, not reopened, and
disposed of according to the vessel’s protocol for clinical waste. If waste must be delivered
ashore, then special precautions are needed, and the port authority should be informed
before waste delivery.
Entering ports in countries where there is an increased risk of COVID-19 exposure (e.g.
China, Italy etc.)?
It is recommended that crew members take the following precautions:
A. Wear face masks when interacting with shore personnel.
B. Keep a distance of at least 1 meter from all arriving on board.
C. Avoid shaking hands.
D. Limit the movement of all shore personnel to only those areas of the vessel where
their attendance is necessary.
8
E. Allocate separate lavatories for visitors, provide them with paper towels only and
disinfect these areas regularly.
F. Make antiseptic gel and face masks available at the top of the vessel’s gangway(s)
and at other strategic locations aboard.
G. Avoid taking on provision and other supplies in ports where there is a high COVID-19
risk. Ensure that, if the vessel is to call at a port in a country with a high COVID-19
risk, the vessel has enough supplies for 14-30 days.
H. Upon leaving a port with a significant COVID-19 risk, the vessel’s crewmembers
should make a written record of their body temperatures for the following 14 days.
We hope that the above information is of assistance to our assureds. All medical
information and procedures have been provided by GVA’s doctors.
For assistance with P&I claims matters please contact claims@hydor.no and call our 24/7
emergency telephone number, +47 977 11 100, if urgent P&I assistance is required outside
office hours.
GVA can be contacted via +357 24 65 96 52.